Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study

Documenti analoghi

• Validation and Reliability of the Thai Pediatric Charcot–Marie–Tooth Quality of Life Outcome Measure
  di: Pimchanok Kulsirichawaroj, et al.
  Pubblicazione: (2025)
• A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A
  di: Isaac R. L. Xu, et al.
  Pubblicazione: (2024)
• Designing and Implementing a Web‐Based Platform for Accurate and Reliable Clinical Outcome Measures and Global Certification for Evaluating Charcot–Marie–Tooth disease
  di: Kayla M. D. Cornett, et al.
  Pubblicazione: (2025)
• Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents
  di: Khian Aun Tan, et al.
  Pubblicazione: (2025)
• Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease
  di: Ah Jin Lee, et al.
  Pubblicazione: (2025)